1. Williams I, Churchill D, Anderson J, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med. 2012;13 Suppl 2:1–85. Plus update available at http://www.bhiva.org/documents/Conferences/Autumn2013/presentations/131114/DuncanChurchill.pdf . Accessed 26 Nov 2013.
2. European AIDS Clinical Society. Guidelines version 7.0, October 2013. 2013. http://www.eacsociety.org/Portals/0/Guidelines_Online_131014.pdf . Accessed 19 Nov 2013.
3. Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012;2(4):a007161.
4. Gras J. Cobicistat. Cytochrome P450 CYP3A inhibitor, anti-HIV agent. Drugs Future. 2012;37(5):315–24.
5. Arya V, Robertson SM, Struble KA, et al. Scientific considerations for pharmacoenhancers in antiretroviral therapy. J Clin Pharmacol. 2012;52(8):1128–33.